-
Mashup Score: 14What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia | Research To Practice - 5 month(s) ago
Program Schedule — Pacific Time 7:00 AM – 7:30 AM — Registration and Breakfast 7:30 AM – 9:30 AM — Educational Meeting Location Manchester Grand Hyatt San Diego 1 Market Place San Diego, California Meeting Room Seaport E-H (Second Level) This event will also be webcast live. Please see Registration tab for details. There is no registration fee for this event. For the in-person symposium in San Diego, preregistration is required as seating is limited. Faculty Farrukh T Awan, MD Professor of Internal
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9
Register for this complimentary event with the “Register Now” button above, which will take you to our Zoom registration page. Join us on Tuesday, October 29 th for this CME/MOC-accredited webinar 5:00 PM – 6:00 PM ET Faculty Suresh S Ramalingam, MD Executive Director, Winship Cancer Institute Roberto C Goizueta Chair for Cancer Research Emory University School of Medicine Atlanta, Georgia Gregory J Riely, MD, PhD Ning Zhao and Ge Li Chair in Lung Cancer Research Vice Chair of Clinical Research Department
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet-
Join @RamalingamMD @WinshipAtEmory and me with @DrNeilLove tomorrow at 5 eastern talking about new data from ESMO and WCLC. https://t.co/Vq2aIx6qHZ https://t.co/oZ1GxhyJEI
-
-
Mashup Score: 9
Register for this complimentary event with the “Register Now” button above, which will take you to our Zoom registration page. Join us on Tuesday, October 29 th for this CME/MOC-accredited webinar 5:00 PM – 6:00 PM ET Faculty Suresh S Ramalingam, MD Executive Director, Winship Cancer Institute Roberto C Goizueta Chair for Cancer Research Emory University School of Medicine Atlanta, Georgia Gregory J Riely, MD, PhD Ning Zhao and Ge Li Chair in Lung Cancer Research Vice Chair of Clinical Research Department
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet-
Join @RamalingamMD @WinshipAtEmory and me with @DrNeilLove tomorrow at 5 eastern talking about new data from ESMO and WCLC. https://t.co/Vq2aIx6qHZ https://t.co/oZ1GxhyJEI
-
-
Mashup Score: 10Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology | Research To Practice - 12 month(s) ago
Register for this complimentary event with the “Register Now” button above, which will take you to our Zoom registration page. Join us on Wednesday, May 8 th for this CME/MOC-accredited webinar 5:00 PM – 6:00 PM ET Faculty Justin F Gainor, MD Director, Center for Thoracic Cancers Program Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Boston, Massachusetts Karen Reckamp,
Source: m.researchtopractice.comCategories: General Medicine News, Oncologists2Tweet-
Join us for the Year in Review Live Webinar | Targeted Therapy for Non-Small Cell Lung Cancer Edition on May 8, 4:30-6pm ET. Dr. Justin Gainor and I will discuss the latest updates with Dr. Neil Love to improve patient care and outcomes. #LCSM https://t.co/1FqK4JD3dB
-
-
Mashup Score: 11
Location Henry B González Convention Center 900 E Market Street San Antonio, Texas Phone: (210) 207-8500 Program Schedule — Central Time 7:30 AM – 8:00 AM — Registration and Breakfast 8:00 AM – 10:00 AM — Educational Meeting Meeting Room Hemisfair Ballroom — C2 (Ballroom Level) This event will also be webcast live. Please see Registration tab for details. There is no registration fee for this event. For the in-person symposium in San Antonio, preregistration is required as seating is limited. Faculty
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet-
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer — Friday, May 3, 2024, San Antonio, TX | Research To Practice -Looking forward to this session with my esteemed colleagues https://t.co/nn8JwNMDH5
-
-
Mashup Score: 9What I Tell My Patients: Integrating New Research Information into Current Clinical Care | Research To Practice - 1 year(s) ago
This unique NCPD symposium series has been designed to assist oncology nurses as they attempt to optimize patient care and interpret recent clinical and research advances. Moderated by Dr Neil Love, each event will feature a stellar faculty to include 2 or 3 clinical investigators and 2 nurse practitioners. To support the theme of the project, each faculty member will develop several minipresentations designed to elucidate “What I Tell My Patients” about specific management issues or topics. The faculty
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet-
One of my favorite ancillary events held at @oncologynursing #ONSCongress Love learning from the fantastic faculty; highlighting great multidisciplinary collaboration! @DrNeilLove https://t.co/UqMqhf6Hcx https://t.co/XUuzTypLT5
-
-
Mashup Score: 0
Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Andrea Cercek, Dr Cathy Eng and Dr John Strickler, moderated by Dr Christopher Lieu. Published February 14, 2024. (Symposium Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers. LEARNING OBJECTIVES Develop an understanding of validated biomarkers of response in patients with metastatic colorectal
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Watch proceedings from our symposium at ASCO GI 2024 on colorectal cancer, moderated by Dr Christopher Lieu. Designated for up to 2.25 AMA PRA Category 1 Credits. https://t.co/r5G5quJdcT https://t.co/OkwLgecaGO
-
-
Mashup Score: 0
Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman. Published February 26, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematology-oncology fellows, surgeons and other allied healthcare professionals involved in the treatment of chronic lymphocytic leukemia. LEARNING OBJECTIVES Individualize the selection of systemic therapy for patients with newly diagnosed chronic lymphocytic leukemia (CLL), considering new research findings, clinical
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Dr Neil Love moderated a discussion with Dr Lindsey Roeker & Dr Jeff Sharman about new data & treatment options for chronic lymphocytic leukemia presented in the past year. The program is designated for a maximum of 1.75 AMA PRA Category 1 Credits. https://t.co/IRPZeLnID9 https://t.co/JPxNtLzP5x
-
-
Mashup Score: 3
Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel. Published February 23, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical and radiation oncologists, urologists and other healthcare providers involved in the treatment of hepatobiliary cancers. LEARNING OBJECTIVES Interrogate recently presented trial results establishing the benefit of anti-PD-L1 antibody therapy in combination with anti-VEGF therapy as adjuvant treatment for patients with hepatocellul
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Dr Neil Love was joined by Dr Ahmed Omar Kaseb and Prof Arndt Vogel to discuss current and emerging therapies for patients with hepatocellular carcinoma and biliary tract cancers. This event is designated for a maximum of 1.75 AMA PRA Category 1 Credits. https://t.co/jrCfJUkcU3 https://t.co/zjVEErsgI6
-
-
Mashup Score: 4
Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer. Published January 31, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of breast cancer. LEARNING OBJECTIVES Implement a long-term clinical plan for the management of localized hormone receptor (HR)-positive, HER2-negative breast cancer, accounting for newly presented clinical
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer (Webinar Video Proceedings) | Research To Practice @elmayermd #bcsm https://t.co/Q0RBog4LJQ
-
If you happen to be at #ASH24 and interested, please join us for this CLL session on Friday morning: What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia | Research To Practice https://t.co/agvmqhoJmS